GSK
The pace of development for CRISPR-based infectious disease assays increased as the pandemic progress
Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project
The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients.
UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects
Led by a group of 10 biopharmaceutical firms, the project will use Olink's proteomic technology to look at participants' plasma levels of roughly 1,500 proteins.
Adaptive Biotechnologies, GlaxoSmithKline Collaborate on MRD Testing
In a non-exclusive deal, GlaxoSmithKline will use Adaptive Biotechnology's NGS-based ClonoSeq test to assess MRD across its hematology portfolio.
UK Biobank Exomes Reveal Loss-of-Function Variants, Potential Disease Ties
More than 198,000 LOF variants turned up in exome sequences from 49,960 UK Biobank participants, including variants with potential ties to human traits.